Business
BullFrog AI uses its bfLEAP AI/ML platform to support therapeutics development, including internal programs and partner projects.
BullFrog AI grew tiny revenue and narrowed its loss, but cash burn, equity erosion, and going-concern risk dominate the read.
The read at a glance✓ Audited against SEC data
- Business mix — AI/ML therapeutics platformNote
- Revenue — $116.7K, up 79.5%OK
- Losses — Net loss narrowed to $6.5MOK
- Cash — Cash from ops was -$5.5MWatch
- Equity — Equity fell 57.0%Watch
- Insiders — 0 purchases / 0 salesNote
- Accounting — Altman-Z distress; other fields unavailableWatch
Leadership changes
From BullFrog AI Holdings, Inc.'s own filings, the day they're filed.
- Josh Blacher · Chief Financial Officer · appointmenteff. 2024-12-12
Latest filings
- 8-K · Company announcement2026-08-20
- 10-Q · Quarterly report2026-08-14
- 8-K · Company announcement2026-06-15
- 10-Q · Quarterly report2026-05-14
- DEF 14A · Annual proxy (pay & governance)2026-04-30
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BullFrog AI Holdings, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.